Jubilant Ingrevia Limited — Board Meeting, 22-10-2024: Outcome of Board Meeting

Jubilant Ingrevia's Board has approved the unaudited financial results for the quarter and half-year ending September 30, 2024. The results show a strong performance in Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The company has also made its first investment in renewable energy, enhancing sustainability efforts. Additionally, 90,192 stock options were granted to employees. Full details are available on their website for further inquiries.